The first network meeting for therapeutic nucleic acids took place in Dresden on April 24, 2025. GWT invited participating network partners to a kick-off meeting at the WTC, providing the perfect opportunity to get to know each other and network.
The aim of the network is to initiate and drive forward therapeutic ideas and developments based on nucleic acids and oligonucleotides in order to promote innovations and therapeutic approaches in this area. A wide variety of players, such as developers, manufacturers, clinics and device manufacturers, contribute their know-how in order to bundle specific expertise along the entire value chain. The targeted transfer of know-how is also driven by the development of new business areas and access to new markets is opened up.
Press release (Link: Press)